The Correlation Between Severity of Postoperative Hypocalcemia and Perioperative Mortality in Chromosome 22q11.2 Microdeletion (22q11DS) Patient After Cardiac-Correction Surgery: A Retrospective Analysis
DOI:
https://doi.org/10.1532/hsf.2957Keywords:
hypocalcemia, velopharyngeal incompetence , cardiac abnormality, aortic cross-clampAbstract
Objectives: The aim of our study was to elucidate the association between severity of postoperative hypocalcemia and the prognosis of the patients with 22q11DS.
Methods: Data retrospectively were collected from 23 children with 22q11DS who underwent cardiac correction surgery. Area under the receiver operating characteristic curve (AUC) and diagnostic odds ratio were calculated to determine the tendency of perioperative mortality rate, according to the minimum levels of serum calcium and the duration of hypocalcemia. A novel risk assessment system for perioperative mortality was established according to these valid parameters.
Results: The death group had lower minimum levels of serum calcium and longer duration of hypocalcemia. The AUC of minimum levels of serum calcium was 0.912 (95% CI: 0.753-1; P = .003) and qualified its high accuracy for perioperative mortality. The AUC of duration of hypocalcemia was 0.804 (95% CI: 0.561-1; P = .03) and qualified its moderate accuracy. The tendency analyses also indicated the correlation between these two parameters and perioperative mortality. Based on the cut-off values from ROC analysis, a novel risk assessment system for perioperative mortality was established according to these two parameters. The patients with the lowest serum calcium level <0.885 mmol/L or duration of the hypocalcemia > 90.33 hours would be sorted into a high-risk group; others were divided into a low-risk group. The diagnostic odds ratio for this assessment system was 143(95% CI: 5.13-3982.52). No significant difference was found with regard to patient age, weight, preoperative serum total calcium, cardiopulmonary bypass (CPB) time, and aortic cross-clamp time between the high- and low-risk groups.
Conclusions: The minimum levels of serum calcium and duration of hypocalcemia were valid predictors for preoperative mortality of 22q11DS patients.
References
Adachi M, Tachibana K, Masuno M, et al. 1998. Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion. European Journal of Pediatrics 157:34-38.
Choi JH, Shin YL, Kim GH, et al. 2005. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Hormone Research 63:294-299.
Cuneo BF, Langman CB, Ilbawi MN, et al. 1996. Driscoll DA. Latent hypoparathyroidism in children with conotruncal cardiac defects. Circulation 93:1702-1708.
Cuturilo G, Drakulic D, Jovanovic I, et al. 2017. The Impact of 22q11.2 Microdeletion on Cardiac Surgery Postoperative Outcome. Pediatric Cardiology. 38: 1680–1685.
de Andrade Sousa A, Salles JM, Soares JM, et al. 2010. Course of ionized calcium after thyroidectomy. World Journal of Surgery 34:987-992.
Fischer JE, Bachmann LM, Jaeschke R. 2003. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Medicine 29:1043-1051.
Goodship J, Cross I, LiLing J, et al. 1998. A population study of chromosome 22q11 deletions in infancy. Archives of Disease in Childhood 79:348-351.
Greig F, Paul E, DiMartino-Nardi J, et al. 1996. Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion. The Journal of Pediatrics 128:563-567.
Kapadia CR, Kim YE, McDonald-McGinn DM, et al. 2008. Parathyroid hormone reserve in 22q11.2 deletion syndrome. Genetics in Medicine: Official Journal of the American College of Medical Genetics 10:224-228.
Kobrynski LJ, Sullivan KE. 2007. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443-1452.
Oh TE, Hutchinson R, Short S, et al. 1993. Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Critical Care Medicine 21:698-705.
Robertie PG, Butterworth JFt, Royster RL, et al. 1991. Normal parathyroid hormone responses to hypocalcemia during cardiopulmonary bypass. Anesthesiology 75:43-48.
Robertie PG, Butterworth JFt, Prielipp RC, et al. 1992. Parathyroid hormone responses to marked hypocalcemia in infants and young children undergoing repair of congenital heart disease. Journal of the American College of Cardiology 20:672-677.
Ryan AK, Goodship JA, Wilson DI, et al. 1997. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. Journal of Medical Genetics 34:798-804.
Schaan BD, Huber J, Leite JC, et al. 2006. Cardiac surgery unmasks latent hypoparathyroidism in a child with the 22q11.2 deletion syndrome. Journal of Pediatric Endocrinology & Metabolism: JPEM 19:943-946.
Shen L, Gu H, Wang D, et al. 2011. Influence of chromosome 22q11.2 microdeletion on postoperative calcium level after cardiac-correction surgery. Pediatric Cardiology 32:904-909.
Taylor SC, Morris G, Wilson D, et al. 2003. Hypoparathyroidism and 22q11 deletion syndrome. Archives of Disease in Childhood 88:520-522.
Yang C, Shen L, Xu Z, et al. 2009. A novel competitive fluorescent multiplex STR polymorphism assay for rapid, reliable and single-tube screening of 22q11.2 copy-number aberrations. Electrophoresis 30:465-471.
